MDT Strangle Strategy
MDT (Medtronic plc), in the Healthcare sector, (Medical - Devices industry), listed on NYSE.
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease.
MDT (Medtronic plc) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $103.66B, a trailing P/E of 21.63, a beta of 0.60 versus the broader market, a 52-week range of 73.31-106.33, average daily share volume of 10.2M, a public-listing history dating back to 1973, approximately 95K full-time employees. These structural characteristics shape how MDT stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.60 indicates MDT has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. MDT pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a strangle on MDT?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current MDT snapshot
As of June 29, 2026, spot at $80.81, ATM IV 24.75%, IV rank 45.20%, expected move 7.10%. The strangle on MDT below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 32-day expiry.
Why this strangle structure on MDT specifically: MDT IV at 24.75% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 7.10% (roughly $5.73 on the underlying). The 32-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated MDT expiries trade a higher absolute premium for lower per-day decay. Position sizing on MDT should anchor to the underlying notional of $80.81 per share and to the trader's directional view on MDT stock.
MDT strangle setup
The MDT strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With MDT near $80.81, the first option leg uses a $85.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed MDT chain at a 32-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 MDT shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $85.00 | $0.80 |
| Buy 1 | Put | $77.00 | $0.94 |
MDT strangle risk and reward
- Net Premium / Debit
- -$173.50
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$173.50
- Breakeven(s)
- $75.27, $86.74
- Risk / Reward Ratio
- Unbounded
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
MDT strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on MDT. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | +$7,525.50 |
| $17.88 | -77.9% | +$5,738.86 |
| $35.74 | -55.8% | +$3,952.21 |
| $53.61 | -33.7% | +$2,165.57 |
| $71.48 | -11.6% | +$378.93 |
| $89.34 | +10.6% | +$260.72 |
| $107.21 | +32.7% | +$2,047.36 |
| $125.08 | +54.8% | +$3,834.00 |
| $142.94 | +76.9% | +$5,620.65 |
| $160.81 | +99.0% | +$7,407.29 |
When traders use strangle on MDT
Strangles on MDT are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the MDT chain.
MDT thesis for this strangle
The market-implied 1-standard-deviation range for MDT extends from approximately $75.08 on the downside to $86.54 on the upside. A MDT long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current MDT IV rank near 45.20% is mid-range against its 1-year distribution, so the IV signal is neutral; the strangle thesis on MDT should anchor more to the directional view and the expected-move geometry. As a Healthcare name, MDT options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to MDT-specific events.
MDT strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. MDT positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move MDT alongside the broader basket even when MDT-specific fundamentals are unchanged. Always rebuild the position from current MDT chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on MDT?
- A strangle on MDT is the strangle strategy applied to MDT (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With MDT stock trading near $80.81, the strikes shown on this page are snapped to the nearest listed MDT chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are MDT strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the MDT strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 24.75%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$173.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a MDT strangle?
- The breakeven for the MDT strangle priced on this page is roughly $75.27 and $86.74 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current MDT market-implied 1-standard-deviation expected move is approximately 7.10%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on MDT?
- Strangles on MDT are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the MDT chain.
- How does current MDT implied volatility affect this strangle?
- MDT ATM IV is at 24.75% with IV rank near 45.20%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.